60 Degrees Pharmaceuticals, Inc. (SXTPW) revenue by segment
SXTPWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3033% below fair value
$0.03−0.00 (-0.38%)
Close on Oct 30, 2026Market cap $3.31MP/E –Yield –
60 Degrees Pharmaceuticals, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q3 24 | Q2 24 | Q1 24 | Q3 23 | Q2 23 | Q1 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Product Revenues - net of Discounts and Rebates | $135.29K | $124.97K | $105.67K | $51.19K | $59.53K | $17.17K | 100.0% | +164.3% |
| Service Revenues | $0 | $0 | $10.79K | – | – | – | 0.0% | – |
By region
From the segment and revenue-disaggregation notes of 60 Degrees Pharmaceuticals's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.